BELLICUM PHARMACEUTICALS INC's ticker is and the CUSIP is 079481404. A total of 26 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $82,211 | -54.2% | 249,123 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $179,369 | -40.0% | 249,123 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $299,000 | +1.0% | 249,123 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $296,000 | -45.0% | 249,123 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $538,000 | +45.0% | 249,123 | 0.0% | 0.00% | +50.0% |
| Q4 2021 | $371,000 | -49.0% | 249,123 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $727,000 | -11.6% | 249,123 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $822,000 | -12.3% | 249,123 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $937,000 | +6.6% | 249,123 | 0.0% | 0.00% | +33.3% |
| Q4 2020 | $879,000 | -46.3% | 249,123 | 0.0% | 0.00% | -57.1% |
| Q3 2020 | $1,637,000 | -11.6% | 249,123 | 0.0% | 0.01% | -12.5% |
| Q2 2020 | $1,851,000 | +57.8% | 249,123 | 0.0% | 0.01% | +14.3% |
| Q1 2020 | $1,173,000 | – | 249,123 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|